<a>
 <h3 class="section-break">
  <span>
   ORIGIN
  </span>
 </h3>
 <p>
  Hundreds of thousands of Facebook users in February 2018 shared an article warning that the pharmaceutical company GlaxoSmithKline had issued a massive recall of Ventolin inhalers, an essential medicine for many people with asthma.
 </p>
 <p>
  The
  <a href="https://webcache.googleusercontent.com/search?q=cache:qdiWQP31TJMJ:https://todayviral.news/2018/02/04/600000-inhalers-recalled-for-defects-share-to-save-a-life/+&amp;cd=1&amp;hl=en&amp;ct=clnk&amp;gl=us" target="_blank">
   post
  </a>
  <strong>
   —
  </strong>
  by TodayViral.News — is a hoax. It rehashes an actual Ventolin recall which took place in April 2017.
 </p>
 <blockquote>
  <p>
   GlaxoSmithKline is recalling nearly 600,000 prescription inhalers over defects, the FDA announced.
  </p>
  <p>
   The voluntary recall targets Ventolin HFA (albuterol sulfate) Inhalation Aerosol, distributed via prescription nationwide.
   <br>
    The manufacturer said the drug delivery system is defective.
   </br>
  </p>
 </blockquote>
 <p>
  TodayViral.News used the sensationalist headline, “600,000 inhalers recalled for defects — ‘Share’ to Save a Life!!” lending a false urgency to the fake story, which could put people’s health at risk.
 </p>
 <p>
  In reality, a check of the web sites of the Food and Drug Administration (
  <a href="https://www.fda.gov/Safety/Recalls/" target="_blank">
   FDA
  </a>
  ) and
  <a href="https://www.gsk.com/en-gb/media/press-releases/" target="_blank">
   GlaxoSmithKline
  </a>
  shows there was no new Ventolin inhaler recall in February 2018. We contacted the FDA for comment on the hoax, but had not heard back by press time.
 </p>
 <p>
  In April 2017, GlaxoSmithKline announced it was recalling almost 600,000 Ventolin HFA inhalers because a propellant leakage in the inhalers had caused them to emit a lower dosage of the medication
  <a href="https://www.reuters.com/article/us-gsk-recall/drugmaker-gsk-recalling-nearly-600000-asthma-inhalers-in-u-s-idUSKBN1762F3" target="_blank">
   albuterol
  </a>
  .
  <span style="font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;">
   The following month, the company
   <a href="https://community.aafa.org/blog/glaxosmithkline-recalling-ventolin-inhalers-for-possible-package-leakage" target="_blank">
    expanded
   </a>
   the recall, including additional batches of the Ventolin HFA inhaler, the Asthma and Allergy Foundation of America reported.
  </span>
  A spokesperson for GlaxoSmithKline told Reuters at the time that the recall did not represent a risk to the public, and that the public were not required to return any affected inhalers.
 </p>
 <p>
  In February 2018, after this article was originally published, the company
  <a href="http://ca.gsk.com/en-ca/media/press-releases/2018/gsk-statement-gsk-voluntary-recall-of-ventolin-diskus-lot-786g-in-canada/" target="_blank">
   announced
  </a>
  a recall of a different product, Ventolin Diskus, which is a dry powder inhaler used to relieve bronchospasm. That recall was limited to Canada.
 </p>
 <div class="article-notation">
  <blockquote class="note">
   <p>
    Updated [20 February 2018]: Added information about post-publication recall of Ventolin Diskus products in Canada.
   </p>
  </blockquote>
 </div>
 <div class="snopes-partner-unit partner-unit-articleFooter">
  <div class="snopes-partner-media">
   <div id="Snopes_content_1">
   </div>
  </div>
 </div>
</a>